<DOC>
	<DOCNO>NCT01140529</DOCNO>
	<brief_summary>Primary hypothesis : Dexmedetomidine equal superior haloperidol placebo treatment psychomotor confusion patient recover heart surgery . Study design : Multi-centre , prospective , randomised , placebo-controlled double-blind study dexmedetomidine vs. haloperidol treatment psychomotor confusion cardiac surgery . Data analyze two step : The primary comparison placebo dexmedetomidine . If effect dexmedetomidine significant , secondary comparison dexmedetomidine haloperidol follow .</brief_summary>
	<brief_title>Dexmedetomidine Treatment Delirium After Heart Surgery</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Confusion</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>Age &gt; 65 year Clinical need treatment psychomotor confusion unresponsive standard analgesic medication ( RASS +2 +3 ) Heart surgery extracorporeal circulation ( ECC ) within 7 day Written inform consent obtain surgery Mentally competent time write informed consent Ongoing neuroleptic , propofol α2 agonist medication Intubated patient Uncompensated acute circulatory failure time randomisation ( severe hypotension mean arterial pressure &lt; 55 mmHg despite volume , vasopressor IABP ) Severe bradycardia without pacemaker backup ( heart rate &lt; 50 beats/min ) AVconduction block IIIII ( without pacemaker backup ) Severe hepatic impairment ( Serum bilirubin &gt; 101 µmol/l ) Lithium therapy</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Dexmedetomidine</keyword>
</DOC>